Resignation of Statutory Auditors

Auditor Resigned MidtermManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹131.55

prior close

₹125.15

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.9%-3.1% vs market

Pharmaceuticals peers, median of 149sector-1.0%-4.0% vs sector

On the reaction day the stock moved 3.1 pts less than Nifty Microcap 250 and 4.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.2

15m

+0.2

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0-1.9-3.1-1.0-4.0

Next day

-8.8-3.1-5.7-1.7-7.0

-7.3-1.6-5.6-0.8-6.5

-5.4-1.3-4.0-0.7-4.7

-1.9-2.0+0.1-1.5-0.4

-0.2-3.6+3.4-3.7+3.5

+1.2-3.4+4.6-3.4+4.6

15d

-5.3-4.0-1.3-4.8-0.5

-4.3-3.4-0.8-4.6+0.3

-5.0-3.1-1.9-4.7-0.3

—-2.8—-7.9—

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Chemo Pharma Laboratories Ltd informed the BSE that its statutory auditor, M/s Sanjay Rane & Associates LLP (FRN: 121089W/W100878), resigned effective July 23, 2025. The auditor cited pre-occupation in other assignments as the reason and explicitly stated there is no dispute with management and no concerns about suppression of information. The auditor was appointed on September 2, 2021 for a five-year term covering FY 2021-22 to FY 2025-26, with their term originally scheduled to expire on March 31, 2026. Their last audit report covered FY 2024-25, submitted on May 29, 2025.

Likely market impact

This is a mid-term auditor resignation well before the scheduled end of the audit firm's tenure, but since the auditor has explicitly confirmed no management dispute and no concerns about information suppression, the immediate governance risk appears low. Shareholders should watch for timely appointment of a new auditor to avoid any disruption to upcoming audits.